Shares of Unicharm (OTCMKTS:UNICY - Get Free Report) gapped up prior to trading on Monday . The stock had previously closed at $3.48, but opened at $3.63. Unicharm shares last traded at $3.51, with a volume of 29,799 shares changing hands.
Unicharm Trading Up 0.9%
The firm has a market cap of $12.30 billion, a price-to-earnings ratio of 17.55 and a beta of 0.25. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.31 and a quick ratio of 1.86. The firm's fifty day moving average is $3.75 and its 200-day moving average is $3.97.
Unicharm (OTCMKTS:UNICY - Get Free Report) last announced its quarterly earnings data on Friday, May 9th. The company reported $0.05 earnings per share (EPS) for the quarter. The business had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.69 billion. Equities analysts anticipate that Unicharm will post 0.17 earnings per share for the current year.
Unicharm Company Profile
(
Get Free Report)
Unicharm Corporation engages in the manufacturing and sale of wellness, feminine, baby and children, kirei, and pet care products in Japan and internationally. The company's baby and child care products, including disposable diapers and wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; feminine care products comprise napkins, tampons, panty liners, sanitary short, panty liners, and other feminine care products under the Sofy, Center-In, and Unicharm brand names; and wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Unicharm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Unicharm wasn't on the list.
While Unicharm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.